USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
13.78
+0.20 (1.47%)
At close: Aug 25, 2026, 4:00 PM EDT
13.98
+0.20 (1.45%)
After-hours: Aug 25, 2026, 4:50 PM EDT
USANA Health Sciences Income Statement
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| 913.36 | 925.26 | 854.5 | 921.01 | 998.6 | 1,186 | |
Revenue Growth | 1.57% | 8.28% | -7.22% | -7.77% | -15.83% | 4.57% |
Cost of Revenue | 206 | 200.85 | 161.21 | 176.69 | 193.89 | 217.9 |
Gross Profit | 707.36 | 724.41 | 693.29 | 744.32 | 804.71 | 968.57 |
Selling, General & Admin | 665.88 | 673.54 | 618.72 | 651.25 | 697.1 | 798.37 |
Operating Expenses | 665.88 | 673.54 | 618.72 | 651.25 | 697.1 | 798.37 |
Operating Income | 41.49 | 50.86 | 74.57 | 93.07 | 107.61 | 170.19 |
Interest Expense | -0.41 | -0.84 | -0.28 | -0.26 | -0.19 | -0.06 |
Interest & Investment Income | 2.11 | 2.42 | 11.32 | 9.64 | 3.79 | 2.52 |
Other Non Operating Income (Expenses) | 1.92 | 2.52 | -1.01 | 0.01 | -2.59 | -2.01 |
EBT Excluding Unusual Items | 45.1 | 54.96 | 84.59 | 102.45 | 108.62 | 170.64 |
Merger & Restructuring Charges | -6.46 | -6.46 | -8.24 | - | - | - |
Impairment of Goodwill | -35.53 | -6.39 | - | - | - | - |
Asset Writedown | -0.58 | -0.58 | - | - | - | - |
Pretax Income | 2.54 | 41.53 | 76.35 | 102.45 | 108.62 | 170.64 |
Income Tax Expense | 31.79 | 30.05 | 34.29 | 38.67 | 39.27 | 54.14 |
Earnings From Continuing Operations | -29.25 | 11.48 | 42.06 | 63.79 | 69.35 | 116.51 |
Minority Interest in Earnings | 7.09 | -0.72 | -0.03 | - | - | - |
Net Income | -22.16 | 10.76 | 42.03 | 63.79 | 69.35 | 116.51 |
Net Income to Common | -22.16 | 10.76 | 42.03 | 63.79 | 69.35 | 116.51 |
Net Income Growth | - | -74.40% | -34.11% | -8.02% | -40.48% | -6.54% |
Shares Outstanding (Basic) | 18 | 19 | 19 | 19 | 19 | 20 |
Shares Outstanding (Diluted) | 18 | 19 | 19 | 19 | 19 | 20 |
Shares Change | -3.10% | -3.07% | -0.95% | 0.18% | -5.08% | -4.29% |
EPS (Basic) | -1.21 | 0.58 | 2.20 | 3.31 | 3.60 | 5.78 |
EPS (Diluted) | -1.21 | 0.58 | 2.19 | 3.30 | 3.59 | 5.73 |
EPS Growth | - | -73.52% | -33.64% | -8.08% | -37.35% | -2.22% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 15.93 | 8.53 | 50.92 | 56.15 | 93.5 | 108.46 |
Free Cash Flow Per Share | 0.87 | 0.46 | 2.66 | 2.90 | 4.84 | 5.33 |
Gross Margin | 77.45% | 78.29% | 81.13% | 80.81% | 80.58% | 81.64% |
Operating Margin | 4.54% | 5.50% | 8.73% | 10.11% | 10.78% | 14.34% |
Profit Margin | -2.43% | 1.16% | 4.92% | 6.93% | 6.94% | 9.82% |
Free Cash Flow Margin | 1.75% | 0.92% | 5.96% | 6.10% | 9.36% | 9.14% |
EBITDA | 73.92 | 83.42 | 89.11 | 105.77 | 121.01 | 183.23 |
EBITDA Margin | 8.09% | 9.02% | 10.43% | 11.48% | 12.12% | 15.44% |
D&A For EBITDA | 32.43 | 32.56 | 14.54 | 12.7 | 13.39 | 13.04 |
EBIT | 41.49 | 50.86 | 74.57 | 93.07 | 107.61 | 170.19 |
EBIT Margin | 4.54% | 5.50% | 8.73% | 10.11% | 10.78% | 14.34% |
Effective Tax Rate | 1253.35% | 72.36% | 44.91% | 37.74% | 36.15% | 31.72% |
Advertising Expenses | - | 43.16 | 4.97 | 4.76 | 5.05 | 12.4 |